文献速递皮肤肿瘤

基底细胞癌与鳞状细胞癌莫氏手术时残留肿瘤的相关因素

Factors associated with residual tumor at time of Mohs micrographic surgery for basal cell and squamous cell carcinomas.
PubMed 文献 · J Am Acad Dermatol · 2024-08-19

单中心回顾性队列分析483例活检证实的基底细胞癌(BCC,n=287)与鳞状细胞癌(SCC,n=196)莫氏显微手术(MMS)病例,采用单阶段标本连续切片穷尽蜡块。MMS时83.3%的BCC和66.8%的SCC存在残留肿瘤(P=.01);临床看似无瘤者中BCC残留68.2%、SCC残留41.5%。男性、高危部位、较小活检尺寸和较大术前尺寸与残留肿瘤显著相关。

要点

  • MMS时多数BCC和SCC病例存在组织学残留肿瘤。
  • 临床看似无瘤者仍有较高比例的组织学残留。
  • 男性、高危部位、较小活检尺寸和较大术前尺寸与残留相关。

核心结论

  • 多数BCC和SCC患者在MMS时存在残留组织学肿瘤,即使临床不明显。
  • 多种因素影响残留肿瘤的存在与否。

研究设计与样本

  • 单阶段MMS标本行en face连续切片以穷尽蜡块,并建立单因素和多因素logistic回归模型。

主要发现

  • MMS时残留肿瘤在BCC中占83.3%、SCC中占66.8%(P=.01)。
  • 活检后临床看似无瘤的患者中,组织学残留肿瘤在BCC中占68.2%、SCC中占41.5%。
  • 残留肿瘤在男性(P=.04)、高危部位(P=.002)、较小活检尺寸(P=.0003)和较大术前尺寸(P<.0001)中显著更常见。

局限性

  • 单中心、回顾性队列。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Residual tumor is not always clinically apparent following biopsy of cutaneous carcinomas, which may prompt patients to question the need for definitive treatment. OBJECTIVE: We investigated the percentage of cases in which residual tumor was histologically present at the time of Mohs micrographic surgery (MMS) for basal cell carcinomas (BCCs) and squamous cell carcinomas (SCCs) and investigated factors associated with residual tumor. METHODS: We examined 483 MMS cases performed for biopsy-proven BCC (n = 287) and SCC (n = 196) between October 2022 and April 2023. Single-stage MMS specimens were step-sectioned en face to exhaust the block. Univariate and multivariable logistic regression models were created. RESULTS: Residual tumor was identified in 83.3% of BCC and 66.8% of SCC at the time of MMS (P = .01). In patients clinically appearing tumor-free following biopsy, residual histologic tumor was identified in 68.2% of BCC and 41.5% of SCC. Residual tumor was significantly more likely in men (P = .04), high-risk sites (P = .002), smaller biopsy sizes (P = .0003), and larger preoperative sizes (P < .0001). LIMITATIONS: Single center, retrospective cohort. CONCLUSION: The majority of patients with BCC and SCC have residual histologic tumor at the time of MMS, oftentimes even when tumor is not clinically apparent. Multiple factors impact the presence/absence of residual tumor.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Thompson KG, Tripathi R, Jedrych J, et al. Factors associated with residual tumor at time of Mohs micrographic surgery for basal cell and squamous cell carcinomas. J Am Acad Dermatol. 2024. PMID: 39168309. doi:10.1016/j.jaad.2024.08.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。